+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Drugs Global Market Report 2020-30: COVID-19 Implications and Growth

  • ID: 5028646
  • Report
  • May 2020
  • Region: Global
  • 400 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Gilead Sciences, Inc.
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • MORE
Pharmaceutical Drugs Global Market Report 2020-30: COVID-19 Implications and Growth from the publisher covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for pharmaceutical drugs which play a critical role in the treatment of patients with COVID-19.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:
Where is the largest and fastest growing market for the pharmaceutical drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Pharmaceutical Drugs Market global report from the publisher answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The pharmaceutical drugs market section of the report gives context. It compares the pharmaceutical drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, pharmaceutical drugs indicators comparison.
Scope

Markets Covered:
1) By Type: Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Respiratory Diseases Drugs
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Subsegments Covered: Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs); Acne; Dermatitis; Psoriasis; Other Drugs for Dermatology Diseases; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity; Antiemetics And Antinauseants; Antidiarrhoeals; Hormonal Contraceptives; Drugs For Benign Prostatic hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Diuretics; Blood Products; Anemia And Other Blood Disorder Drugs; Drugs For Rheumatoid Arthritis; Muscle Relaxants; Others - Musculoskeletal Disorders Drugs; Analgesics; Anti-Parkinson drugs; Anesthetics; Anti-Epileptics; Other CNS drugs; Lung Cancer; Pancreatic Cancer; Breast Cancer; Prostate Cancer; Ovarian Cancer; Colorectal Cancer; Gastric Cancer; Kidney Cancer; Brain Tumor; Thyroid Cancer; Skin Cancer; Bladder Cancer; Cervical Cancer; Blood Cancer; Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma); Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations

Companies Mentioned: Novartis AG; Sanofi S.A.; Pfizer Inc.; Gilead Sciences, Inc.; Johnson & Johnson

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, pharmaceutical drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Gilead Sciences, Inc.
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • MORE
1. Executive Summary

2. Report Structure

3. Pharmaceutical Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Pharmaceutical Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Pharmaceutical Drugs Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Pharmaceutical Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Pharmaceutical Drugs Market Trends And Strategies

8. Pharmaceutical Drugs Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, Value ($ Billion)
8.2.1. Drivers Of The Market
8.2.2. Restraints On The Market
8.3. Forecast Market Growth, Value ($ Billion)
8.3.1. Drivers Of The Market
8.3.2. Restraints On The Market

9. Pharmaceutical Drugs Market Regional Analysis
9.1. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
9.2. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
9.3. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Region

10. Pharmaceutical Drugs Market Segmentation
10.1. Global Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Cardiovascular Drugs
  • Dermatology Drugs
  • Gastrointestinal Drugs
  • Genito-Urinary Drugs
  • Hematology Drugs
  • Anti-Infective Drugs
  • Metabolic Disorders Drugs
  • Musculoskeletal Disorders Drugs
  • Central Nervous System Drugs
  • Oncology Drugs
  • Ophthalmology Drugs
  • Respiratory Diseases Drugs
10.2. Global Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
10.3. Global Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oral
  • Parenteral
  • Others
10.4. Global Pharmaceutical Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Branded Drugs
  • Generic Drugs
10.5. Global Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
11. Pharmaceutical Drugs Market Segments
11.1. Global Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)
11.2. Global Dermatology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Acne; Dermatitis; Psoriasis; Other Drugs for Dermatology Diseases
11.3. Global Gastrointestinal Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity; Antiemetics And Antinauseants; Antidiarrhoeals
11.4. Global Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Hormonal Contraceptives; Drugs For Benign Prostatic hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Diuretics
11.5. Global Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Blood Products; Anemia And Other Blood Disorder Drugs
11.6. Global Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Antibiotics; Antivirals; Antifungals; Others (Anthelminthic, Antiprotozoal)
11.7. Global Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Anti Diabetics drugs; Anti-Thyroid drugs; Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)
11.8. Global Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Drugs For Rheumatoid Arthritis; Muscle Relaxants; Others - Musculoskeletal Disorders Drugs
11.9. Global Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Analgesics; Anti-Parkinson drugs; Anesthetics; Anti-Epileptics; Other CNS drugs
11.10. Global Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Lung Cancer; Pancreatic Cancer; Breast Cancer; Prostate Cancer; Ovarian Cancer; Colorectal Cancer; Gastric Cancer; Kidney Cancer; Brain Tumor; Thyroid Cancer; Skin Cancer; Bladder Cancer; Cervical Cancer; Blood Cancer; Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
11.11. Global Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
11.12. Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations

12. Pharmaceutical Drugs Market Metrics
12.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, 2015-2023, Global
12.2. Per Capita Average Pharmaceutical Drugs Market Expenditure, 2015-2023, Global

13. Asia-Pacific Pharmaceutical Drugs Market
13.1. Asia-Pacific Pharmaceutical Drugs Market Overview
13.2. Asia-Pacific, Pharmaceutical Drugs Market, 2019, By Country, Value ($ Billion)
13.3. Asia-Pacific, Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
13.4. Asia-Pacific, Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
13.5. Asia-Pacific, Pharmaceutical Drugs Market Metrics
13.5.1. Per Capita Average Pharmaceutical Drugs Expenditure, 2015-2023, Asia-Pacific Countries
13.5.2. Number of Enterprises, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Enterprises, 2019, Asia-Pacific Countries
13.5.3. Number of Employees, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Employees, 2019, Asia-Pacific Countries
13.6. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7. Asia-Pacific Pharmaceutical Drugs Market: Country Analysis
13.7.1. China Pharmaceutical Drugs Market
13.7.1.1. China Pharmaceutical Drugs Market Overview
13.7.1.2. China Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.2. Australia Pharmaceutical Drugs Market
13.7.2.1. Australia Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.3. Hong Kong Pharmaceutical Drugs Market
13.7.3.1. Hong Kong Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.4. India Pharmaceutical Drugs Market
13.7.4.1. India Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5. Indonesia Pharmaceutical Drugs Market
13.7.5.1. Indonesia Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6. Japan Pharmaceutical Drugs Market
13.7.6.1. Japan Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.7. Malaysia Pharmaceutical Drugs Market
13.7.7.1. Malaysia Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.8. New Zealand Pharmaceutical Drugs Market
13.7.8.1. New Zealand Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.9. Philippines Pharmaceutical Drugs Market
13.7.9.1. Philippines Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.10. Singapore Pharmaceutical Drugs Market
13.7.10.1. Singapore Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.11. South Korea Pharmaceutical Drugs Market
13.7.11.1. South Korea Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.12. Thailand Pharmaceutical Drugs Market
13.7.12.1. Thailand Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.13. Vietnam Pharmaceutical Drugs Market
13.7.13.1. Vietnam Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Western Europe Pharmaceutical Drugs Market
14.1. Western Europe Pharmaceutical Drugs Market Overview
14.2. Western Europe, Pharmaceutical Drugs Market, 2019, By Country, Value ($ Billion)
14.3. Western Europe, Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
14.4. Western Europe, Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
14.5. Western Europe, Pharmaceutical Drugs Market Metrics
14.5.1. Per Capita Average Pharmaceutical Drugs Expenditure, 2015-2023, Western Europe Countries
14.5.2. Number of Enterprises, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Enterprises, 2019, Western Europe Countries
14.5.3. Number of Employees, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Employees, 2019, Western Europe Countries
14.6. Western Europe Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7. Western Europe Pharmaceutical Drugs Market: Country Analysis
14.7.1. Austria Pharmaceutical Drugs Market
14.7.1.1. Austria Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.2. Belgium Pharmaceutical Drugs Market
14.7.2.1. Belgium Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.3. Denmark Pharmaceutical Drugs Market
14.7.3.1. Denmark Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.4. Finland Pharmaceutical Drugs Market
14.7.4.1. Finland Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.5. France Pharmaceutical Drugs Market
14.7.5.1. France Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.6. Germany Pharmaceutical Drugs Market
14.7.6.1. Germany Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.7. Ireland Pharmaceutical Drugs Market
14.7.7.1. Ireland Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.8. Italy Pharmaceutical Drugs Market
14.7.8.1. Italy Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.9. Netherlands Pharmaceutical Drugs Market
14.7.9.1. Netherlands Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.10. Norway Pharmaceutical Drugs Market
14.7.10.1. Norway Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.11. Portugal Pharmaceutical Drugs Market
14.7.11.1. Portugal Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.12. Spain Pharmaceutical Drugs Market
14.7.12.1. Spain Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.13. Sweden Pharmaceutical Drugs Market
14.7.13.1. Sweden Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.14. Switzerland Pharmaceutical Drugs Market
14.7.14.1. Switzerland Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.15. UK Pharmaceutical Drugs Market
14.7.15.1. UK Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. Eastern Europe Pharmaceutical Drugs Market
15.1. Eastern Europe Pharmaceutical Drugs Market Overview
15.2. Eastern Europe, Pharmaceutical Drugs Market, 2019, By Country, Value ($ Billion)
15.3. Eastern Europe, Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
15.4. Eastern Europe, Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
15.5. Eastern Europe, Pharmaceutical Drugs Market Metrics
15.5.1. Per Capita Average Pharmaceutical Drugs Expenditure, 2015-2023, Eastern Europe Countries
15.5.2. Number of Enterprises, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Enterprises, 2019, Eastern Europe Countries
15.5.3. Number of Employees, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Employees, 2019, Eastern Europe Countries
15.6. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7. Eastern Europe Pharmaceutical Drugs Market: Country Analysis
15.7.1. Czech Republic Pharmaceutical Drugs Market,
15.7.1.1. Czech Republic Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.2. Poland Pharmaceutical Drugs Market
15.7.2.1. Poland Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.3. Romania Pharmaceutical Drugs Market
15.7.3.1. Romania Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.4. Russia Pharmaceutical Drugs Market
15.7.4.1. Russia Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. North America Pharmaceutical Drugs Market
16.1. North America Pharmaceutical Drugs Market Overview
16.2. North America, Pharmaceutical Drugs Market, 2019, By Country, Value ($ Billion)
16.3. North America, Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
16.4. North America, Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
16.5. North America, Pharmaceutical Drugs Market Metrics
16.5.1. Per Capita Average Pharmaceutical Drugs Expenditure, 2015-2023, North America Countries
16.5.2. Number of Enterprises, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Enterprises, 2019, North America Countries
16.5.3. Number of Employees, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Employees, 2019, North America Countries
16.6. North America Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7. North America Pharmaceutical Drugs Market: Country Analysis
16.7.1. Canada Pharmaceutical Drugs Market
16.7.1.1. Canada Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.2. Mexico Pharmaceutical Drugs Market
16.7.2.1. Mexico Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.3. USA Pharmaceutical Drugs Market
16.7.3.1. USA Pharmaceutical Drugs Market Overview
16.7.3.2. USA Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. South America Pharmaceutical Drugs Market
17.1. South America Pharmaceutical Drugs Market Overview
17.2. South America, Pharmaceutical Drugs Market, 2019, By Country, Value ($ Billion)
17.3. South America, Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
17.4. South America, Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
17.5. South America, Pharmaceutical Drugs Market Metrics
17.5.1. Per Capita Average Pharmaceutical Drugs Expenditure, 2015-2023, South America Countries
17.5.2. Number of Enterprises, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Enterprises, 2019, South America Countries
17.5.3. Number of Employees, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Employees, 2019, South America Countries
17.6. South America Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7. South America Pharmaceutical Drugs Market: Country Analysis
17.7.1. Argentina Pharmaceutical Drugs Market
17.7.1.1. Argentina Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.2. Brazil Pharmaceutical Drugs Market
17.7.2.1. Brazil Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.3. Chile Pharmaceutical Drugs Market
17.7.3.1. Chile Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.4. Colombia Pharmaceutical Drugs Market
17.7.4.1. Colombia Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.5. Peru Pharmaceutical Drugs Market
17.7.5.1. Peru Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.6. Venezuela Pharmaceutical Drugs Market
17.7.6.1. Venezuela Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Middle East Pharmaceutical Drugs Market
18.1. Middle East Pharmaceutical Drugs Market Overview
18.2. Middle East, Pharmaceutical Drugs Market, 2019, By Country, Value ($ Billion)
18.3. Middle East, Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
18.4. Middle East, Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
18.5. Middle East, Pharmaceutical Drugs Market Metrics
18.5.1. Per Capita Average Pharmaceutical Drugs Expenditure, 2015-2023, Middle East Countries
18.5.2. Number of Enterprises, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Enterprises, 2019, Middle East Countries
18.5.3. Number of Employees, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Employees, 2019, Middle East Countries
18.6. Middle East Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7. Middle East Pharmaceutical Drugs Market: Country Analysis
18.7.1. Saudi Arabia Pharmaceutical Drugs Market
18.7.1.1. Saudi Arabia Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.2. Israel Pharmaceutical Drugs Market
18.7.2.1. Israel Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.3. Turkey Pharmaceutical Drugs Market
18.7.3.1. Turkey Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.4. UAE Pharmaceutical Drugs Market
18.7.4.1. UAE Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Africa Pharmaceutical Drugs Market
19.1. Africa Pharmaceutical Drugs Market Overview
19.2. Africa, Pharmaceutical Drugs Market, 2019, By Country, Value ($ Billion)
19.3. Africa, Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
19.4. Africa, Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
19.5. Africa, Pharmaceutical Drugs Market Metrics
19.5.1. Per Capita Average Pharmaceutical Drugs Expenditure, 2015-2023, Africa Countries
19.5.2. Number of Enterprises, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Enterprises, 2019, Africa Countries
19.5.3. Number of Employees, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Employees, 2019, Africa Countries
19.6. Africa Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
19.7. Africa Pharmaceutical Drugs Market: Country Analysis
19.7.1. Egypt Pharmaceutical Drugs Market
19.7.1.1. Egypt Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
19.7.2. Nigeria Pharmaceutical Drugs Market
19.7.2.1. Nigeria Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
19.7.3. South Africa Pharmaceutical Drugs Market
19.7.3.1. South Africa Pharmaceutical Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

20. Pharmaceutical Drugs Market Competitive Landscape
20.1. Competitive Market Overview
20.2. Market Shares
20.3. Company Profiles
20.3.1. Novartis AG
20.3.1.1. Company Overview
20.3.1.2. Products And Services
20.3.1.3. Strategy
20.3.1.4. Financial Performance
20.3.2. Sanofi S.A.
20.3.2.1. Company Overview
20.3.2.2. Products And Services
20.3.2.3. Strategy
20.3.2.4. Financial Performance
20.3.3. Pfizer Inc.
20.3.3.1. Company Overview
20.3.3.2. Products And Services
20.3.3.3. Strategy
20.3.3.4. Financial Performance
20.3.4. Gilead Sciences, Inc.
20.3.4.1. Company Overview
20.3.4.2. Products And Services
20.3.4.3. Strategy
20.3.4.4. Financial Performance
20.3.5. Johnson & Johnson
20.3.5.1. Company Overview
20.3.5.2. Products And Services
20.3.5.3. Strategy
20.3.5.4. Financial Performance

21. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market

22. Market Background: Pharmaceuticals Market
22.1. Pharmaceuticals Market Characteristics
22.2. Pharmaceuticals Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
22.3. Global Pharmaceuticals Market, 2019, By Region, Value ($ Billion)
22.4. Global Pharmaceuticals Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
22.5. Global Pharmaceuticals Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

23. Recommendations
23.1. Global Pharmaceutical Drugs Market In 2023- Growth Countries
23.2. Global Pharmaceutical Drugs Market In 2023- Growth Segments
23.3. Global Pharmaceutical Drugs Market In 2023- Growth Strategies

24. Appendix
24.1. NAICS Definitions Of Industry Covered In This Report
24.2. Abbreviations
24.3. Currencies
24.4. Research Inquiries
24.5. About the Publisher

25. Copyright And Disclaimer
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Gilead Sciences, Inc.
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • MORE
North America was the largest region in the global pharmaceutical drugs market, accounting for 44% of the market in 2019. Asia Pacific was the second largest region accounting for 27% of the global pharmaceutical drugs market. Africa was the smallest region in the global pharmaceutical drugs market.

There has been an increasing push towards the development of personalized medicine. Personalized medicine is also referred to as precision medicine, the idea of which is to provide medical care according to patient’s individual characteristics, needs, preferences and genetic makeup. According to a survey by the Tufts Center, 94% of pharmaceutical companies have invested in personal medicine research. For instance, Bayer is investing in personalized medicine for the development of therapies for cardiovascular diseases.

The pharmaceutical drug market consists of sales of goods and related services by entities (organizations, sole traders and partnerships) that produce and sell pharmaceutical drugs used to treat various diseases. This industry includes establishments that produce drugs such as cardiovascular drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs and other drugs used to treat cardiovascular diseases, rare genetic disorders, infections, metabolic disorders, cancers, respiratory diseases and others.

The global pharmaceutical drugs market is expected to grow from $947.9 billion in 2019 to $970.4 billion in 2020 at a compound annual growth rate (CAGR) of 2.4%. The growth is mainly due to the COVID-19 outbreak and spiked demand for drugs such as anti-infectives (antivirals and antibiotics in particular), respiratory drugs, and anti-diabetic drugs, among others. However, the growth is not significant as COVID-19 pandemic has affected industries across the globe including the pharmaceutical sector. The restrictions on non-essential medical services, drug shortages due to slowed production of drugs because of extended factory closures in various countries, shortage of APIs and other chemicals, and rise in prices of key ingredients have been the roadblocks obstructing its growth. The market is then expected to recover and grow at a CAGR of 7% from 2021 and reach $1273.7 billion in 2023.
Note: Product cover images may vary from those shown
4 of 5
  • Novartis AG
  • Sanofi S.A.
  • Pfizer Inc.
  • Gilead Sciences, Inc.
  • Johnson & Johnson
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll